Bill Snyder

Address outlines VUMC’s strategic direction

In his State of the Medical Center address on Wednesday, Jeff Balser, M.D., Ph.D., President and CEO of Vanderbilt University Medical Center (VUMC), and Dean of the Vanderbilt University School of Medicine, described a “Strategic Compass” to help the Medical Center continue to “grow and shine” in the years to come.

Brown named interim director of Institute of Chemical Biology

H. Alex Brown, Ph.D., the Bixler-Johnson-Mayes Professor in the Department of Pharmacology, has been named interim director of the Vanderbilt Institute of Chemical Biology (VICB).

Vanderbilt’s Dugan, Patel, Wallace set for Discovery Lecture

Three Vanderbilt University neuroscientists on the forefront of research in autism, addiction and Alzheimer’s disease will discuss their cutting-edge investigations during the next Flexner Discovery Lecture on Thursday, Nov. 3.

Iadecola set for Oates Lectureship in Clinical Pharmacology

Costantino Iadecola, M.D., an expert in the molecular pathology of ischemic brain injury and neurodegeneration at Weill Cornell Medical College in New York, will present the 10th annual Meredith S. and John A. Oates Lectureship in Clinical Pharmacology on Nov. 3.

DNA damage response protein

Vanderbilt researchers have determined that a previously uncharacterized protein responds to DNA replication stress and has an essential role in maintaining the integrity of the genome.

Preparing for a return of pox

To prepare for the potential of a smallpox return, Vanderbilt researchers are isolating and studying naturally occurring antibodies from the blood of previously infected or immunized people.

1 65 66 67 68 69 109